CB07-Exatecan 是一种 ADC 药物-Linker 偶联物 (ADC drug-Linker conjugate),可用于 ADCs 的合成。CB07-Exatecan 与 Trastuzumab 缀合的 ADC 能抑制 HER2 阳性癌细胞的生长。CB07-Exatecan 可用于癌症的研究。 粉末-20°C 3年,4°C 2年在溶剂中-80°C 6个月,-20°C 1个月 CB07 Hexatecan is an ADC drug linker conjugate that can be used for the synthesis of ADCs. The ADC conjugated with CB07 Hexatecan and Trastuzumab can inhibit the growth of HER2 positive cancer cells. CB07 Hexatecan can be used for cancer research. Powder -20°C 3 years,4°C 2 years;In solvent -80°C 6 months,-20°C 1 month
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
CB07-Exatecan
CAS number:2879247-31-9 molecular formula:C71H94FN11O22
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | - | ||
| CAS number | 2879247-31-9 | molecular formula | C71H94FN11O22 |
| molecular weight | 1472.56 g/mol | Exact mass | ≥98% |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





